The FY 2025 HHS Evaluation Plan details the Department of Health and Human Services’ (HHS) efforts to answer the priority questions presented in the current HHS Evidence Building Plan. This plan provides both an overview of HHS evaluation activities planned for FY 2025 and detailed information for each new and continuing evaluation effort.
Report
Reports
Displaying 1 - 10 of 230. 10 per page. Page 1.
Advanced SearchReport
The Fiscal Impact of Refugees and Asylees at the Federal, State, and Local Levels from 2005-2019
Between 1990 and 2022, the United States welcomed over 2.1 million refugees and accepted over 800,000 asylees. While the purpose of granting visas to refugees and asylees is humanitarian, they do impact the United States economically. This analysis estimates the fiscal impact of refugees and asylees on federal, state, and local governments from 2005 to 2019.
Report
Comparing Prescription Drugs in the U.S. and Other Countries: Prices and Availability
ASPE contracted with RAND Health Care to carry out three studies analyzing data on U.S. prescription drug prices and availability in comparison to drug prices and availability in other Organisation for Economic Co-operation and Development (OECD) countries. In 2022, U.S. prices across all drugs (brands and generics) were nearly 2.78 times as high as prices in the comparison countries. U.S.
Report
State Efforts to Coordinate Provider Directory Accuracy
Provider directories are lists of in-network providers produced by health care plans. They are an important tool for individuals seeking health care providers, and for regulators who monitor the adequacy of health plans’ provider networks.
Report
Claims and Provider Payment Data Gaps for Responding to COVID-19
This report and accompanying discussion by ASPE and NORC highlights the claims data limitations identified during the COVID-19 Public Health Emergency Health (PHE) and provides considerations to address these limitations. The report identifies that limitations related to claims data were existing issues, exacerbated by, but not unique to, the COVID-19 PHE.
Report, Research Brief
Reconnecting Youth: Evidence Gap Map
Evidence Gap Map: Research Report and Overview
Report, Research Brief
Reconnecting Youth: Compendium of Programs
Compendium of Programs: Research Report and Overview The Reconnecting Youth compendium of programs provides an overview of 78 programs and the practices they employ to support young people who experience disconnection from school and work during their transition to adulthood.
Report
Health Information Technology Adoption and Utilization in Long-Term and Post-Acute Care Settings
This paper provides an overview of Health Information Technology (HIT) adoption and utilization in long-term and post-acute care (LTPAC) settings. This study found that LTPAC have adopted electronic health records (EHRs) to support clinical and business needs. Interoperable exchange of health information however is not routine or widely used.
Report
National Plan to Address Alzheimer’s Disease: 2023 Update
Through the National Plan, HHS and its federal partners work to improve the trajectory of ADRD research, support people living with dementia and their caregivers, and encourage action to reduce risk factors. This page will soon provide the HTML version of the National Plan 2023 Update; the PDF is available now.
Report
Competition in Prescription Drug Markets, 2017-2022
The cornerstone of a well-functioning market is competition. President Biden’s Executive Order 14036, “Promoting Competition in the American Economy” identified a lack of competition as a key driver for problems across economic sectors.